Fig. 2.

Kaplan-Meier curves showing the survival differences between two risk groups defined by NRI and skeletal muscle loss. In the whole patient group, patients were dichotomized by the median value of NRI (a) and dSMI (b). A subgroup analysis was undertaken in the recurrence group and patients were divided according to NRI (c) and dSMI (d). By pathologic tumor stage, analyses were performed by two variables in stage 2 (e and f) and stage 3 (g and h) gastric cancer patients